Categories: All postsCannabis

The Canadian government has turned marijuana into a “gong show”, says Brett Wilson

Brett Wilson on BNN Bloomberg

Brett Wilson has a bone to pick with the Canadian government over how it has handled the rollout of legal weed, where too many bureaucrats have had too much say in how the rec pot business is run.

“We had a running start on the world when Trudeau and his colleagues said, ‘We want to legalize recreational marijuana.’ Unfortunately, the framework was an only in-government approach where they allowed both provincial and municipal interference —and I call it interference because it’s a complete gong show trying to get from processing into distribution and then into the dispensaries,” says Wilson, chairman of Canoe Financial and former Dragons’ Den panelist, to BNN Bloomberg on Monday.

“The jobs are there, the work is there but regulatory impediments are extraordinary,” he said.

The story so far has Canada making marijuana for medical purposes legal back in 2001 and then after a decade and a couple of iterations of the medical cannabis act, recreational bud became a reality in the fall of 2018, with edible products set to become regulated in October of this year.

Last month, Health Canada made changes to the licensed producer application process, now requiring applicants to have grow facilities already constructed before applying. The intent was to cut down on the number of approved applications that in the end didn’t amount to verified businesses, although many have criticized the new rules as another example of a heavy-handed approach.

“We go from a situation where if you wanted to submit an application, you submit your paperwork and you sit and wait to hear back from Health Canada,” said Matt Maurer, to BNN Bloomberg in May. “Now you’re asked to build a $30-million to $40-million facility before you even submit your application.” Wilson, who is an advisor for cannabis investment fund Green Acre Capital, says the process in US states like Colorado has been much smoother.

“We’ve over regulated the Canadian industry relative to what they’re doing in the US. The same time frame to take a year and a half to get going here in Canada, I can do that in three months in the US,” Wilson says. “They are open for business.”

“Every level wants to regulate [in Canada],” he says. “We have the province regulating the number of pot shops in the city, then the city will come in and say, ‘Well, we don’t want one too close to this school.’ And so there’s all sorts of regulatory bureaucracy —and let’s never assume that the government is best known for efficiency— so you layer on three levels of inefficiency and no wonder it’s a gong show.”

More Cantech Cannabis

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

15 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

21 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

22 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

23 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

2 days ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

2 days ago